EN PL

EMA: Progress in science, medicines, health

07.05.2015
The annual report published by the European Medicines Agency (EMA) today focuses on the Agency’s key priorities, including the evaluation of medicines and the support to research and development of new and innovative medicines. In 2014, the Agency recommended 102 new medicines for marketing authorisation, both for human (82) and animal (20) use. The number of applications for orphan designation increased by 63% and requests for scientific advice for human medicines by 16% compared to 2013. Developers of medicines are making more and better use of EMA’s tools aimed at helping patients to get access to effective and safe medicines more quickly.